KOCHEVAR KAREN

CAVA Director Kochevar sold 15,000 shares (92.0% of holdings) for $2.1M on 2024-11-19, reducing stake to 1,307 shares

Karen Kochevar, a director, executed a substantial reduction in her CAVA position, selling 15,000 shares worth $2,133,450.00 at $142.23 per share on 2024-11-19, leaving her with only 1,307 shares post-transaction. This represents a 92.0% reduction in her holdings. The stock currently trades at $144.80, near its 52-week high of $147.80, and has gained 6.3% over the past 30 days and 18.7% over 90 days. Her prior sales at CAVA show mixed timing outcomes: two 2024-06-17 sales posted positive 90-day returns of +29.6% and +31.4%, while two 2024-08-27 sales showed positive 30-day returns; most recent CAVA sales occurred on 2024-11-15. Across her cross-ticker history, her 7 prior sells averaged -6.0% at 30 days and +31.2% at 90 days, with a 0.00% well-timed rate at the 90-day mark, indicating stocks generally appreciated after her sales.

Director Karen Kochevar sold 15,000 CAVA shares at $140.00 on 2024-11-15; reduced stake by 92.0% to 1,307 shares remaining.

Director Karen Kochevar executed a substantial stake reduction, selling 15,000 shares (92.0% of her pre-transaction holdings) at $140.00 on 2024-11-15, leaving only 1,307 shares. The sale occurred near the 52-week high of $147.80 (at -4.4% below peak) and follows a strong 90-day price appreciation of +37.3%, creating an unfavorable timing context relative to her same-ticker history: 0 of 2 prior CAVA sales with measurable 90-day outcomes were well-timed, both posting +29.6% and +31.4% gains after she sold. The near-complete exit from a large director position, combined with CAVA's elevated valuation (P/E of 642.05) and the insider's historical difficulty timing exits at this ticker, suggests a structural decision to exit rather than a discretionary trim.

Director Karen Kochevar sells 20,000 CAVA shares for $2,367,400 on 2024-08-27; reduces stake by 93.9%.

Director Karen Kochevar executed two separate sales totaling 20,000 shares for $2,367,400 at a blended average price of $118.37, reducing her holdings from 21,307 to 1,307 shares (a 93.9% reduction in stake). The timing is notable: she sold at prices ($118.58 and $118.16) near the 52-week high of $125.80, and the current price of $110.87 is now 11.9% below that peak, suggesting the sales occurred during a relative strength window. Her prior sales at CAVA on 2024-06-17 (four transactions) each showed 30-day declines ranging from -11.8% to -13.8%, establishing a pattern of selling into strength without subsequent recovery within 30 days. The company trades at a P/E of 503.95 with strong annual revenue growth of 29.2%, but the high multiple and director's near-complete exit together warrant monitoring of whether this signals a fundamental reassessment of valuation or is a liquidity event by a departing board member.

Director Karen Kochevar sells entire 20,972 share position at blended $93.60 for $1,963,066.50.

Director Karen Kochevar executed 4 separate sales totaling 20,972 shares for $1,963,066.50 on 2024-06-17, completely exiting her shareholding at a blended average price of $93.60. This represents a full liquidation of her position at a price near CAVA's 52-week high of $95.39, with the stock up 39.6% over the prior 90 days and up 23.4% over the prior 30 days. The complete divestiture—a 100.0% reduction in holdings—merits investor attention given the company's elevated valuation metrics (P/E of 433.59) and the scale of the exit relative to the timing within a strong uptrend.